Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy-Reference-Cited by-同舟云学术

Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy

Published:2008-09 Issue:9 Volume:18 Page:983-988
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Smith Terry J.¹²³,Tsai Chieh Chih¹,Shih Mei-Ju¹,Tsui Shanli¹,Chen Beiling¹,Han Rui¹,Naik Vibha⁴,King Chris S.¹,Press Chris¹,Kamat Shweta¹,Goldberg Robert A.²,Phipps Richard P.⁵,Douglas Raymond S.¹²³,Gianoukakis Andrew G.³⁶

Affiliation:

1. Division of Molecular Medicine, Department of Medicine, Harbor-UCLA Medical Center, Torrance, California.

2. Jules Stein Eye Institute, Los Angeles, California.

3. David Geffen School of Medicine at UCLA, Los Angeles, California.

4. Harbor-UCLA Medical Center, Torrance, California.

5. Department of Environmental Medicine and the Lung Biology and Disease Program, University of Rochester School of Medicine and Dentistry, Rochester, New York.

6. Division of Endocrinology and Metabolism, Harbor-UCLA Medical Center, Torrance, California.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2007.0404

Reference53 articles.

1. Insights Into the Pathogenesis of Thyroid-Associated Orbitopathy

2. Fibroblast biology in thyroid diseases

3. Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

4. Connective Tissue, Glycosaminoglycans, and Diseases the Thyroid*

5. Immunohistochemical and Ultrastructural Studies on the Exenterated Orbital Tissues of a Patient with Graves' Disease

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAPP-A as a Potential Target in Thyroid Eye Disease;The Journal of Clinical Endocrinology & Metabolism;2024-05-16

2. Comparison of orbital fibroblasts from Graves’ ophthalmopathy and healthy control;Heliyon;2024-04

3. GSDMD mediated pyroptosis induced inflammation of Graves’ orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway;Experimental Eye Research;2024-03

4. Teprotumumab in thyroid eye disease;Saudi Journal of Ophthalmology;2024-01

5. Teprotumumab for the treatment of thyroid eye disease;Expert Opinion on Biological Therapy;2023-01-29